{"id":94,"date":"2023-12-22T06:50:36","date_gmt":"2023-12-22T04:50:36","guid":{"rendered":"https:\/\/www.ipsen.com\/be\/?page_id=94"},"modified":"2025-03-27T14:05:28","modified_gmt":"2025-03-27T12:05:28","slug":"oncologie-cancer-prostate-tumeurs-neuroendocrines-carcinome-du-rein-lymphome-folliculaire-sarcome-epithelioide-carcinome-hepatocellulaire-thyroide","status":"publish","type":"page","link":"https:\/\/www.ipsen.com\/be\/fr\/oncologie-cancer-prostate-tumeurs-neuroendocrines-carcinome-du-rein-lymphome-folliculaire-sarcome-epithelioide-carcinome-hepatocellulaire-thyroide\/","title":{"rendered":"Oncologie"},"content":{"rendered":"    <section class=\"sub-page-banner bg-img\" style=\"background-image:url(https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/sites\/7\/2024\/02\/21101130\/03-1_Sciences-Oncology_Module-Banner_1920X280.jpg)\">\n        <div class=\"container content-sec\" role=\"main\" id=\"main\">\n            <nav aria-label=\"breadcrumb\">\n            <ol class=\"breadcrumb\">\n                <li class=\"breadcrumb-item\"><a href=\"https:\/\/www.ipsen.com\/be\/fr\/\">Accueil<\/a><\/li><li class=\"breadcrumb-item active\"><a href=\"#\" aria-current=\"page\">Science &#8211; Oncologie<\/a><\/li><\/ol>\n            <\/nav>            <h1 class=\"visible\">Oncologie<\/h1>\n            <p class=\"visible\">Engagez \u00e0 prolonger et \u00e0 am\u00e9liorer la vie.<\/p>\n        <\/div>\n    <\/section>\n\n\n    <section class=\"title-text \">\n        <div class=\"container\">\n            <div class=\"title-text-inner\" style=\"background-color:#DBEAF5;\">\n                <!-- If heading is enabled then it's visible -->\n                <div class=\"text-head-dash visible\">\n                                            <span class=\"dash\"><\/span> \n                        <p class=\"heading-para\">\n                            UN BUT COMMUN                        <\/p>\n                                        \n                <\/div>\n\n                <!-- If subtitle is enabled then it's visible -->\n                <div class=\"text-head-dash hidden\">\n                                            <h2 class=\"heading-para\">\n                                                    <\/h2>\n                    \n                <\/div>\n                \n                <!-- If description is enabled then it's visible -->\n                <div class=\"text-parbase visible\">\n                    <p><p>Avec plus de 35 ans d&rsquo;exp\u00e9rience en oncologie, nous partageons un objectif : prolonger la vie des patients, am\u00e9liorer la sant\u00e9 et cr\u00e9er un impact positif pour les patients et la soci\u00e9t\u00e9.<\/p>\n<\/p>\n                <\/div>\n\n                <!-- If button is enabled then it's visible -->\n                \n            <\/div>\n        <\/div>\n    <\/section>\n\n\n<!-- Ipsen Content Overlay Start -->\n<section class=\"two-col-image-section\">\n    <div class=\"container two-img-section-innner\">\n                <!-- Ipsen Content Overlay Variation Two Start -->\n                <div class=\"row \">\n                    <div class=\"col-xs-12 col-sm-12 col-md-6 column-1 \">\n                        <div id=\"image-carousel\" class=\"img-video-section carousel\" data-bs-ride=\"carousel\">\n                            <div class=\"carousel-inner\">\n                                                                        <div class=\"carousel-item active\">\n                                            <img decoding=\"async\" src=\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/sites\/7\/2024\/02\/25162926\/Steve-kidney-cancer-img-01-none-scaled.jpg\" title=\"Image info\" alt=\"Image info\" >\n                                        <\/div>\n                                                            <\/div>\n                                                    <\/div>\n                    <\/div>\n                    <div class=\" col-xs-12 col-sm-12 col-md-6 column-2 \">\n                        <div class=\" section-content\">\n                                                                                            <h3 class=\"section-head-two\">\n                                        Notre engagement en oncologie                                    <\/h3>\n                                                                                            <p class=\"section-para \">\n                                        Notre riche h\u00e9ritage et notre expertise en innovation et traitement en oncologie nous permettent de nous concentrer sur ce qui est le plus important : am\u00e9liorer la vie des personnes atteintes d\u2019un cancer, aujourd\u2019hui et demain.                                    <\/p>\n                                                                                <\/div>\n                    <\/div>\n                    <!-- Ipsen Content Overlay Variation Two End -->\n                <\/div>\n        <!-- Ipsen Content Overlay Variation two End -->\n            <\/div>\n<\/section>\n<!-- Ipsen Content Overlay End -->\n\n<!-- Text & Media Block Code -->\n<section class=\"two-col-section text-media-section\">\n    <div class=\"container two-section-innner section-reverse\">\n        <div class=\"response-inner\" style=\"background-image: url('')\">\n            <div class=\"row section-reverse\">\n                <div class=\"col-xs-12 col-sm-12 col-md-6\">\n                                                    <div class=\"img-video-section\">\n                                <img decoding=\"async\" src=\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/sites\/7\/2024\/02\/25164057\/Stephen-NET-img-04-hd-scaled.jpg\" alt=\"Media Image\" title=\"Media Image\">\n                            <\/div>\n                                        <\/div>\n                <div class=\" col-xs-12 col-sm-12 col-md-6\">\n                    <div class=\"section-content\">\n                        <div class=\"heading-dash\">\n                                                    <\/div>\n                        <p class=\"section-head-two\">\n                            Notre engagement envers les patients                        <\/p>\n                        <p>Le diagnostic d&rsquo;un cancer bouleverse une vie. Bien qu&rsquo;il existe plus d&rsquo;options de traitement que jamais aujourd&rsquo;hui, il y a un besoin urgent d&rsquo;innovation. Nous sommes r\u00e9solument engag\u00e9s \u00e0 servir les patients atteints de cancers parmi les plus difficiles \u00e0 traiter. Nous travaillons avec plus de 100 associations de patients atteints de cancer dans le monde et soutenons les programmes de sensibilisation \u00e0 des th\u00e9matiques qui sont importantes pour les communaut\u00e9s que nous servons.<\/p>\n                            <a \n                            aria-label=\"\"  \n                                role=\"link\" \n                                class=\"btn-link section-btn cta-visible\"\n                                href=\"https:\/\/www.ipsen.com\/be\/fr\/patients\/\" \n                                target=\"_self\"\n                            > \n                                En savoir plus \n                            <\/a>\n                    <\/div>\n                <\/div>\n            <\/div>\n        <\/div>\n    <\/div>\n<\/section>\n\n\n\n\n<!--Graphics Cards Carousel Start Here-->\n    <section class=\"graphic-card bgColor-enabled\" style='background: #DBEAF5;' data-displaycards=\"2\">\n        <div class=\"container\">\n            <div class=\"text-graph-inner\">\n                <div class=\"row\">\n                    <!--Graphic info section-->\n                    <div class=\"column-1 col-xl-12 col-md-12 col-sm-12\">\n                        <div class=\"text-graph-heading\">\n                            <h2 class=\"charcoal-grey visible\">Chiffres cl\u00e9s<\/h3>\n                            <p class=\"text-graph-para charcoal-grey hidden\"><\/p>\n                        <\/div>\n                    <\/div><!--Graphic info section over here -->\n\n                    <!--Graphic detail section-->\n                    <div class=\"column-2 col-xl-12 col-md-12 col-sm-12\">\n                        <!-- graphic-card carousel start here -->\n                                                    <div class=\"text-graph-carousel\">\n                                <div class=\"glider-contain multiple\">\n                                                                                    <div class=\"text-graph-content-btn\">\n                                                    <button aria-label=\"Pr\u00e9c\u00e9dent\" class=\"glider-graphic-card-prev\"><span><\/span><\/button>\n                                                    <button aria-label=\"Suivant\" class=\"glider-graphic-card-next\"><span><\/span><\/button>\n                                                <\/div>\n                                    \n                                <div class=\"glider-graphic-card\">\n                                                                                                                    <div class=\"text-graphic\">\n                                                <div class=\"text-graph-row\">\n                                                    <div class=\"column-1\">\n                                                                                                                        <div class=\"text-graph-img visible\">\n                                                                                                                                            <img decoding=\"async\" src=\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/sites\/7\/2024\/02\/21101346\/ONCOLOGY_PICTO_72x72pix.jpg\" alt=\"Un portefeuille robuste de produits en oncologie\" title=\"Un portefeuille robuste de produits en oncologie\" \/> \n                                                                                                                                    <\/div>\n                                                                                                            <\/div>\n                                                    <div class=\"column-2\">\n                                                        <div class=\"text-graph-content\">\n                                                            <div class=\"text-graph-title\">\n                                                                <h3>Un portefeuille robuste de produits en oncologie<\/h3>\n                                                            <\/div>\n                                                            <div class=\"text-graph-desc\">\n                                                                <p><p>Ipsen poss\u00e8de six actifs mis \u00e0 disposition des personnes atteintes d&rsquo;un cancer dans le monde.<\/p>\n<\/p>\n                                                            <\/div>\n                                                        <\/div>\n                                                    <\/div>\n                                                <\/div>\n                                            <\/div>\n                                                                                                                                                            <div class=\"text-graphic\">\n                                                <div class=\"text-graph-row\">\n                                                    <div class=\"column-1\">\n                                                                                                                        <div class=\"text-graph-img visible\">\n                                                                                                                                            <img decoding=\"async\" src=\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/sites\/7\/2024\/02\/21101410\/EXPERIENCEE_PICTO_72x72pix-1.jpg\" alt=\"Plus de 35 ans d'exp\u00e9rience en oncologie\" title=\"Plus de 35 ans d'exp\u00e9rience en oncologie\" \/> \n                                                                                                                                    <\/div>\n                                                                                                            <\/div>\n                                                    <div class=\"column-2\">\n                                                        <div class=\"text-graph-content\">\n                                                            <div class=\"text-graph-title\">\n                                                                <h3>Plus de 35 ans d&rsquo;exp\u00e9rience en oncologie<\/h3>\n                                                            <\/div>\n                                                            <div class=\"text-graph-desc\">\n                                                                <p><p>Ipsen est un acteur de l&rsquo;oncologie depuis 1986. Notre portefeuille comprend aujourd&rsquo;hui des traitements pour les cancers du rein, du foie, de la thyro\u00efde, du pancr\u00e9as, de la prostate et du sein, ainsi que les tumeurs neuroendocrines, le lymphome folliculaire et le sarcome \u00e9pith\u00e9lio\u00efde.<\/p>\n<\/p>\n                                                            <\/div>\n                                                        <\/div>\n                                                    <\/div>\n                                                <\/div>\n                                            <\/div>\n                                                                                                                                                            <div class=\"text-graphic\">\n                                                <div class=\"text-graph-row\">\n                                                    <div class=\"column-1\">\n                                                                                                                        <div class=\"text-graph-img visible\">\n                                                                                                                                            <img decoding=\"async\" src=\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/sites\/7\/2024\/02\/21101438\/WORLDWIDE_PICTO_72x72pix.jpg\" alt=\"Cancer du rein\" title=\"Cancer du rein\" \/> \n                                                                                                                                    <\/div>\n                                                                                                            <\/div>\n                                                    <div class=\"column-2\">\n                                                        <div class=\"text-graph-content\">\n                                                            <div class=\"text-graph-title\">\n                                                                <h3>Cancer du rein<\/h3>\n                                                            <\/div>\n                                                            <div class=\"text-graph-desc\">\n                                                                <p><p>Plus de 400 000 nouveaux cas de cancer du rein sont diagnostiqu\u00e9s chaque ann\u00e9e dans le monde. 90 % d&rsquo;entre eux sont des carcinomes \u00e0 cellules r\u00e9nales (RCC). Jusqu&rsquo;\u00e0 30 % des patients pr\u00e9sentent, au moment du diagnostic, un RCC avanc\u00e9 ou m\u00e9tastatique.<\/p>\n<\/p>\n                                                            <\/div>\n                                                        <\/div>\n                                                    <\/div>\n                                                <\/div>\n                                            <\/div>\n                                                                                                                                                            <div class=\"text-graphic\">\n                                                <div class=\"text-graph-row\">\n                                                    <div class=\"column-1\">\n                                                                                                                        <div class=\"text-graph-img visible\">\n                                                                                                                                            <img decoding=\"async\" src=\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/sites\/7\/2024\/02\/21101502\/PARTNERSHIP_PICTO_72x72pix.jpg\" alt=\"Investir dans l'avenir de l'oncologie \" title=\"Investir dans l'avenir de l'oncologie \" \/> \n                                                                                                                                    <\/div>\n                                                                                                            <\/div>\n                                                    <div class=\"column-2\">\n                                                        <div class=\"text-graph-content\">\n                                                            <div class=\"text-graph-title\">\n                                                                <h3>Investir dans l&rsquo;avenir de l&rsquo;oncologie <\/h3>\n                                                            <\/div>\n                                                            <div class=\"text-graph-desc\">\n                                                                <p><p>Guid\u00e9s par une strat\u00e9gie ax\u00e9e sur la science et les besoins non satisfaits des patients, nous continuons d\u2019\u00e9largir notre portefeuille en oncologie. En explorant le potentiel de nouvelles modalit\u00e9s telles que les conjugu\u00e9s anticorps-m\u00e9dicament et les immunoth\u00e9rapies engageant les cellules T, nous esp\u00e9rons ouvrir de nouvelles options th\u00e9rapeutiques pour les personnes atteintes de cancer dans le monde entier.<\/p>\n<\/p>\n                                                            <\/div>\n                                                        <\/div>\n                                                    <\/div>\n                                                <\/div>\n                                            <\/div>\n                                                                                                            <\/div>\n                            <\/div>\n                                            <\/div> <!-- graphic-card carousel end here -->\n                <\/div> <!--Graphic detail section over here with 12 grid -->   \n            <\/div><!--row ended here-->\n        <\/div> <!-- graph-inner ended here -->\n        \n            <div class=\"more-result-btn\">\n                                            <\/div>\n        <\/div> <!--Container class ended here -->\n    <\/section>\n<!--Graphics Cards Carousel End Here-->\n\n\n \n\n\n    <!--Accordion Cards Start Here-->\n    <section class=\"accordion\" data-according-id=\"1631518806\">\n        <div class=\"container\">\n            <div class=\"row\">\n                <!--Accordion info section-->\n                <div class=\"column-1 col-xl-12 col-md-12 col-sm-12\">\n                    <div class=\"accordian-info\">\n                        <h2 class=\"accordian-heading visible\">Notre expertise en oncologie<\/h3>\n                        <p class=\"accordian-summary visible\">L\u2019oncologie est le plus important des secteurs th\u00e9rapeutiques d\u2019Ipsen et nous sommes fiers de jouer un r\u00f4le central dans les traitements disponibles pour les patients atteints de 9 formes diff\u00e9rentes de cancer.<\/p>\n                    <\/div>\n                <\/div><!--Accordion info section over here -->\n\n                <div class=\"col-xl-12 col-lg-12 col-md-12 col-sm-12\">\n                    <div class=\"accordion accor-group\" id=\"accordionExample1631518806\">\n                         \n                                    <!-- Accordion with Expandable panel & FAQs -->\n                                    <div class=\"accordion-item accor-item\">\n                                        <p class=\"accordion-header accor-head-para\" id=\"expHeading0\">\n                                            <button class=\"accordion-button accor-btn collapsed\" type=\"button\" data-bs-toggle=\"collapse\" data-bs-target=\"#expHeading16315188060\" aria-expanded=\"false\" aria-controls=\"expHeading16315188060\">\n                                                Le carcinome du rein (RCC) avanc\u00e9                                            <\/button>\n                                        <\/p>\n                                        <div id=\"expHeading16315188060\" class=\"accordion-collapse collapse \" aria-labelledby=\"expHeading0\" data-bs-parent=\"#accordionExample1631518806\">\n                                            <div class=\"accordion-body\">\n                                                <div class=\"accordion-data\">\n                                                    <p><p>Plus de 400 000 nouveaux cas de cancer du rein sont diagnostiqu\u00e9s chaque ann\u00e9e dans le monde, dont 90\u00a0% sont des carcinomes du rein (RCC). Au moment du diagnostic, jusqu&rsquo;\u00e0 30 % des patients pr\u00e9sentent un RCC avanc\u00e9 ou m\u00e9tastatique. S\u2019il est d\u00e9tect\u00e9 au stade pr\u00e9coce, le taux de survie \u00e0 cinq ans est \u00e9lev\u00e9. Pour les patients atteints d\u2019un RCC localement avanc\u00e9 ou \u00e0 un stade avanc\u00e9 m\u00e9tastatique, le taux de survie \u00e0 cinq ans est beaucoup plus faible, autour de 12\u00a0%.<\/p>\n<\/p>\n                                                    <div class=\"cta-block hidden\" >\n                                                                                                            <\/div>\n                                                <\/div>\n                                            <\/div>\n                                        <\/div>\n                                    <\/div>\n                             \n                                    <!-- Accordion with Expandable panel & FAQs -->\n                                    <div class=\"accordion-item accor-item\">\n                                        <p class=\"accordion-header accor-head-para\" id=\"expHeading1\">\n                                            <button class=\"accordion-button accor-btn collapsed\" type=\"button\" data-bs-toggle=\"collapse\" data-bs-target=\"#expHeading16315188061\" aria-expanded=\"false\" aria-controls=\"expHeading16315188061\">\n                                                Le cancer du sein                                            <\/button>\n                                        <\/p>\n                                        <div id=\"expHeading16315188061\" class=\"accordion-collapse collapse \" aria-labelledby=\"expHeading1\" data-bs-parent=\"#accordionExample1631518806\">\n                                            <div class=\"accordion-body\">\n                                                <div class=\"accordion-data\">\n                                                    <p><p>Le cancer du sein est le cancer le plus r\u00e9pandu dans le monde et le plus fr\u00e9quent chez la femme; 65 \u00e0 75 % des cancers du sein sont hormonosensibles.<\/p>\n<\/p>\n                                                    <div class=\"cta-block hidden\" >\n                                                                                                            <\/div>\n                                                <\/div>\n                                            <\/div>\n                                        <\/div>\n                                    <\/div>\n                             \n                                    <!-- Accordion with Expandable panel & FAQs -->\n                                    <div class=\"accordion-item accor-item\">\n                                        <p class=\"accordion-header accor-head-para\" id=\"expHeading2\">\n                                            <button class=\"accordion-button accor-btn collapsed\" type=\"button\" data-bs-toggle=\"collapse\" data-bs-target=\"#expHeading16315188062\" aria-expanded=\"false\" aria-controls=\"expHeading16315188062\">\n                                                Le sarcome \u00e9pith\u00e9lio\u00efde                                             <\/button>\n                                        <\/p>\n                                        <div id=\"expHeading16315188062\" class=\"accordion-collapse collapse \" aria-labelledby=\"expHeading2\" data-bs-parent=\"#accordionExample1631518806\">\n                                            <div class=\"accordion-body\">\n                                                <div class=\"accordion-data\">\n                                                    <p><p>Le sarcome \u00e9pith\u00e9lio\u00efde est un cancer rare appel\u00e9 sarcome des tissus mous. Il se manifeste par une excroissance de cellules dans les tissus mous et peut appara\u00eetre n&rsquo;importe o\u00f9 sur le corps. Dans la plupart des cas, le sarcome \u00e9pith\u00e9lio\u00efde se d\u00e9veloppe dans les tissus mous sous la peau d\u2019un doigt, d\u2019une main, d\u2019un avant-bras, d&rsquo;un genou ou d\u2019une jambe. Il provoque la formation d&rsquo;une ou plusieurs petites excroissances ou grosseurs sous la peau, et peut souvent \u00eatre confondu avec d&rsquo;autres pathologies. Plusieurs excroissances peuvent appara\u00eetre jusqu&rsquo;\u00e0 ce que la personne touch\u00e9e demande un avis m\u00e9dical . Le sarcome \u00e9pith\u00e9lio\u00efde affecte le plus souvent les adolescents et les jeunes adultes, mais peut \u00e9galement toucher les personnes plus \u00e2g\u00e9es. Le sarcome des tissus mous repr\u00e9sente environ 1 % des cancers chez l&rsquo;adulte. Le sarcome \u00e9pith\u00e9lio\u00efde repr\u00e9sente environ 1 % des sarcomes des tissus mous recens\u00e9s chaque ann\u00e9e aux \u00c9tats-Unis.<\/p>\n<\/p>\n                                                    <div class=\"cta-block hidden\" >\n                                                                                                            <\/div>\n                                                <\/div>\n                                            <\/div>\n                                        <\/div>\n                                    <\/div>\n                             \n                                    <!-- Accordion with Expandable panel & FAQs -->\n                                    <div class=\"accordion-item accor-item\">\n                                        <p class=\"accordion-header accor-head-para\" id=\"expHeading3\">\n                                            <button class=\"accordion-button accor-btn collapsed\" type=\"button\" data-bs-toggle=\"collapse\" data-bs-target=\"#expHeading16315188063\" aria-expanded=\"false\" aria-controls=\"expHeading16315188063\">\n                                                Le lymphome folliculaire                                            <\/button>\n                                        <\/p>\n                                        <div id=\"expHeading16315188063\" class=\"accordion-collapse collapse \" aria-labelledby=\"expHeading3\" data-bs-parent=\"#accordionExample1631518806\">\n                                            <div class=\"accordion-body\">\n                                                <div class=\"accordion-data\">\n                                                    <p><p>Le lymphome folliculaire est un type de lymphome non hodgkinien (LNH), repr\u00e9sentant environ 20 \u00e0 30 % de l\u2019ensemble des LNH, qui sont des cancers du syst\u00e8me lymphatique. Le syst\u00e8me lymphatique fait partie du syst\u00e8me immunitaire. Le lymphome folliculaire se d\u00e9veloppe lorsque l\u2019organisme produit des lymphocytes B anormaux, un type de globule blanc qui aide normalement \u00e0 combattre les infections. Lorsqu\u2019un patient a un lymphome, les lymphocytes anormaux s\u2019accumulent dans les ganglions lymphatiques ou d\u2019autres organes. Entre 15 000 et 20 000 cas de lymphome folliculaire sont diagnostiqu\u00e9s chaque ann\u00e9e aux \u00c9tats-Unis. La plupart des diagnostics sont \u00e9tablis \u00e0 des stades avanc\u00e9s.<\/p>\n<\/p>\n                                                    <div class=\"cta-block hidden\" >\n                                                                                                            <\/div>\n                                                <\/div>\n                                            <\/div>\n                                        <\/div>\n                                    <\/div>\n                             \n                                    <!-- Accordion with Expandable panel & FAQs -->\n                                    <div class=\"accordion-item accor-item\">\n                                        <p class=\"accordion-header accor-head-para\" id=\"expHeading4\">\n                                            <button class=\"accordion-button accor-btn collapsed\" type=\"button\" data-bs-toggle=\"collapse\" data-bs-target=\"#expHeading16315188064\" aria-expanded=\"false\" aria-controls=\"expHeading16315188064\">\n                                                Le carcinome h\u00e9patocellulaire                                            <\/button>\n                                        <\/p>\n                                        <div id=\"expHeading16315188064\" class=\"accordion-collapse collapse \" aria-labelledby=\"expHeading4\" data-bs-parent=\"#accordionExample1631518806\">\n                                            <div class=\"accordion-body\">\n                                                <div class=\"accordion-data\">\n                                                    <p><p>Le carcinome h\u00e9patocellulaire est aussi appel\u00e9 h\u00e9patome ou CHC. Il s&rsquo;agit du type le plus courant de cancer primitif du foie. Ce type de cancer du foie se d\u00e9veloppe au niveau des principales cellules du foie, appel\u00e9es h\u00e9patocytes. Il est plus fr\u00e9quent chez les personnes atteintes de cirrhose, lorsque le foie pr\u00e9sente des l\u00e9sions cicatricielles notamment caus\u00e9es par le virus de l\u2019h\u00e9patite B ou C, ou par l\u2019exc\u00e8s d\u2019alcool \u00e0 long terme. Plus de 900 000 nouveaux cas de cancer du foie, dont 90 % de CHC, sont diagnostiqu\u00e9s dans le monde chaque ann\u00e9e. Le CHC devrait causer 1 million de d\u00e9c\u00e8s par an dans le monde d&rsquo;ici 2030.<\/p>\n<\/p>\n                                                    <div class=\"cta-block hidden\" >\n                                                                                                            <\/div>\n                                                <\/div>\n                                            <\/div>\n                                        <\/div>\n                                    <\/div>\n                             \n                                    <!-- Accordion with Expandable panel & FAQs -->\n                                    <div class=\"accordion-item accor-item\">\n                                        <p class=\"accordion-header accor-head-para\" id=\"expHeading5\">\n                                            <button class=\"accordion-button accor-btn collapsed\" type=\"button\" data-bs-toggle=\"collapse\" data-bs-target=\"#expHeading16315188065\" aria-expanded=\"false\" aria-controls=\"expHeading16315188065\">\n                                                Les tumeurs neuroendocrines et le syndrome carcino\u00efde                                             <\/button>\n                                        <\/p>\n                                        <div id=\"expHeading16315188065\" class=\"accordion-collapse collapse \" aria-labelledby=\"expHeading5\" data-bs-parent=\"#accordionExample1631518806\">\n                                            <div class=\"accordion-body\">\n                                                <div class=\"accordion-data\">\n                                                    <p><p>Les tumeurs neuroendocrines (TNE) sont un groupe de tumeurs peu communes qui se d\u00e9veloppent dans les cellules du syst\u00e8me neuroendocrinien dans l\u2019ensemble du corps. Les TNE touchent aussi bien les hommes que les femmes, g\u00e9n\u00e9ralement \u00e2g\u00e9s de 50 \u00e0 60 ans, bien qu\u2019elles puissent affecter n\u2019importe qui \u00e0 n\u2019importe quel \u00e2ge. Les trois zones o\u00f9 les TNE sont le plus souvent pr\u00e9sentes dans l\u2019organisme sont le tractus gastro-intestinal, le pancr\u00e9as et les poumons. On estime que le nombre de personnes nouvellement diagnostiqu\u00e9es avec des TNE est en augmentation en raison d\u2019une plus grande sensibilisation et de meilleures m\u00e9thodes de diagnostic, avec environ 35 personnes sur 100 000 vivant actuellement avec des TNE dans le monde. Les sympt\u00f4mes des TNE ne sont souvent pas distincts et sont difficiles \u00e0 identifier, ce qui entra\u00eene des retards dans le diagnostic, pr\u00e8s d\u2019un tiers des personnes mettant au moins 5 ans \u00e0 recevoir un diagnostic de TNE.<\/p>\n<p>Le syndrome carcino\u00efde est l\u2019ensemble des sympt\u00f4mes que peuvent ressentir certaines personnes atteintes d\u2019une tumeur neuroendocrine. Il est plus fr\u00e9quent lorsque la tumeur s\u2019est propag\u00e9e au foie, car des hormones telles que la s\u00e9rotonine sont lib\u00e9r\u00e9es dans la circulation sanguine.<\/p>\n<\/p>\n                                                    <div class=\"cta-block hidden\" >\n                                                                                                            <\/div>\n                                                <\/div>\n                                            <\/div>\n                                        <\/div>\n                                    <\/div>\n                             \n                                    <!-- Accordion with Expandable panel & FAQs -->\n                                    <div class=\"accordion-item accor-item\">\n                                        <p class=\"accordion-header accor-head-para\" id=\"expHeading6\">\n                                            <button class=\"accordion-button accor-btn collapsed\" type=\"button\" data-bs-toggle=\"collapse\" data-bs-target=\"#expHeading16315188066\" aria-expanded=\"false\" aria-controls=\"expHeading16315188066\">\n                                                Le cancer du pancr\u00e9as                                            <\/button>\n                                        <\/p>\n                                        <div id=\"expHeading16315188066\" class=\"accordion-collapse collapse \" aria-labelledby=\"expHeading6\" data-bs-parent=\"#accordionExample1631518806\">\n                                            <div class=\"accordion-body\">\n                                                <div class=\"accordion-data\">\n                                                    <p><p>Le cancer du pancr\u00e9as est une maladie syst\u00e9mique agressive dont l\u2019incidence continue de cro\u00eetre et qui devrait devenir la deuxi\u00e8me cause la plus fr\u00e9quente de d\u00e9c\u00e8s li\u00e9s au cancer d\u2019ici 2030. L\u2019ad\u00e9nocarcinome pancr\u00e9atique (PDAC) est le type de cancer le plus courant qui se forme dans le pancr\u00e9as. Plus de 60 000 personnes sont diagnostiqu\u00e9es chaque ann\u00e9e aux \u00c9tats-Unis et pr\u00e8s de 500 000 dans le monde. En raison de l\u2019absence de sympt\u00f4mes sp\u00e9cifiques aux premiers stades et du manque de d\u00e9pistage pr\u00e9coce, la PDAC est souvent d\u00e9tect\u00e9e tardivement, apr\u00e8s que la maladie se soit propag\u00e9e \u00e0 d\u2019autres parties du corps. Lorsque les sympt\u00f4mes apparaissent, ils sont souvent similaires \u00e0 ceux d\u2019autres maladies, comme la perte de poids, les douleurs abdominales et la jaunisse.<\/p>\n<\/p>\n                                                    <div class=\"cta-block hidden\" >\n                                                                                                            <\/div>\n                                                <\/div>\n                                            <\/div>\n                                        <\/div>\n                                    <\/div>\n                             \n                                    <!-- Accordion with Expandable panel & FAQs -->\n                                    <div class=\"accordion-item accor-item\">\n                                        <p class=\"accordion-header accor-head-para\" id=\"expHeading7\">\n                                            <button class=\"accordion-button accor-btn collapsed\" type=\"button\" data-bs-toggle=\"collapse\" data-bs-target=\"#expHeading16315188067\" aria-expanded=\"false\" aria-controls=\"expHeading16315188067\">\n                                                Le cancer de la prostate                                            <\/button>\n                                        <\/p>\n                                        <div id=\"expHeading16315188067\" class=\"accordion-collapse collapse \" aria-labelledby=\"expHeading7\" data-bs-parent=\"#accordionExample1631518806\">\n                                            <div class=\"accordion-body\">\n                                                <div class=\"accordion-data\">\n                                                    <p><p>Le cancer de la prostate se d\u00e9veloppe g\u00e9n\u00e9ralement lentement, de sorte qu\u2019il ne peut y avoir aucun sympt\u00f4me pendant de nombreuses ann\u00e9es. Plus de 1,4 million de nouveaux cas de cancer de la prostate ont \u00e9t\u00e9 diagnostiqu\u00e9s dans le monde en 2020. Il s\u2019agit du quatri\u00e8me cancer le plus fr\u00e9quent dans la population mondiale et du deuxi\u00e8me cancer le plus fr\u00e9quent chez l\u2019homme.<\/p>\n<\/p>\n                                                    <div class=\"cta-block hidden\" >\n                                                                                                            <\/div>\n                                                <\/div>\n                                            <\/div>\n                                        <\/div>\n                                    <\/div>\n                             \n                                    <!-- Accordion with Expandable panel & FAQs -->\n                                    <div class=\"accordion-item accor-item\">\n                                        <p class=\"accordion-header accor-head-para\" id=\"expHeading8\">\n                                            <button class=\"accordion-button accor-btn collapsed\" type=\"button\" data-bs-toggle=\"collapse\" data-bs-target=\"#expHeading16315188068\" aria-expanded=\"false\" aria-controls=\"expHeading16315188068\">\n                                                Le cancer de la thyro\u00efde diff\u00e9renci\u00e9 r\u00e9fractaire \u00e0 l&rsquo;iode radioactif                                            <\/button>\n                                        <\/p>\n                                        <div id=\"expHeading16315188068\" class=\"accordion-collapse collapse \" aria-labelledby=\"expHeading8\" data-bs-parent=\"#accordionExample1631518806\">\n                                            <div class=\"accordion-body\">\n                                                <div class=\"accordion-data\">\n                                                    <p><p>En 2020, plus de 580 000 nouveaux cas de cancer de la thyro\u00efde ont \u00e9t\u00e9 diagnostiqu\u00e9s dans le monde. Le cancer de la thyro\u00efde est le neuvi\u00e8me cancer le plus fr\u00e9quent \u00e0 l\u2019\u00e9chelle mondiale. Son incidence est trois fois plus \u00e9lev\u00e9e chez les femmes que chez les hommes. Les tumeurs canc\u00e9reuses de la thyro\u00efde ont des formes diff\u00e9renci\u00e9es, m\u00e9dullaires ou anaplasiques. Le cancer de la thyro\u00efde diff\u00e9renci\u00e9 (DTC) repr\u00e9sente environ 90 \u00e0 95 % des cas. Le DTC est g\u00e9n\u00e9ralement trait\u00e9 par chirurgie, suivie d\u2019une ablation du tissu thyro\u00efdien restant par traitement \u00e0 l\u2019iode radioactif (RAI), mais environ 5 \u00e0 15 % des cancers r\u00e9sistent au traitement par RAI. Les patients qui d\u00e9veloppent un DTC r\u00e9fractaire \u00e0 l\u2019iode radioactif (RAI-R) ont une dur\u00e9e de survie m\u00e9diane estim\u00e9e de trois \u00e0 cinq ans.<\/p>\n<\/p>\n                                                    <div class=\"cta-block hidden\" >\n                                                                                                            <\/div>\n                                                <\/div>\n                                            <\/div>\n                                        <\/div>\n                                    <\/div>\n                                                <\/div>\n                <\/div> \n            <\/div>\n        <\/div>\n    <\/section>\n    <!--Accordion Cards End Here-->\n\n\n<!-- Ipsen Content Overlay Start -->\n<section class=\"two-col-image-section\">\n    <div class=\"container two-img-section-innner\">\n                <!-- Ipsen Content Overlay Variation Two Start -->\n                <div class=\"row \">\n                    <div class=\"col-xs-12 col-sm-12 col-md-6 column-1 \">\n                        <div id=\"image-carousel\" class=\"img-video-section carousel\" data-bs-ride=\"carousel\">\n                            <div class=\"carousel-inner\">\n                                                                        <div class=\"carousel-item active\">\n                                            <img decoding=\"async\" src=\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/sites\/7\/2024\/02\/21101617\/Module-9_Oncology-clinical-trial_191209_0729.jpg\" title=\"Image info\" alt=\"Image info\" >\n                                        <\/div>\n                                                            <\/div>\n                                                    <\/div>\n                    <\/div>\n                    <div class=\" col-xs-12 col-sm-12 col-md-6 column-2 \">\n                        <div class=\" section-content\">\n                                                                                            <h3 class=\"section-head-two\">\n                                        Les essais cliniques d&rsquo;Ipsen en oncologie                                     <\/h3>\n                                                                                            <p class=\"section-para \">\n                                        \u00a0Nous travaillons sans rel\u00e2che pour amener de nouveaux traitements au stade d&rsquo;essai clinique et ainsi r\u00e9pondre aux besoins m\u00e9dicaux non satisfaits des patients.                                     <\/p>\n                                                                                                <a \n                                            role=\"link\" \n                                            class=\"btn-link section-btn cta-visible\" \n                                            href=\"https:\/\/www.ipsen.com\/fr\/essais-cliniques\/\" \n                                            aria-label=\"\" \n                                            target=\"_blank\"\n                                        >\n                                            En savoir plus                                         <\/a>    \n                                    <\/button>\n                                                    <\/div>\n                    <\/div>\n                    <!-- Ipsen Content Overlay Variation Two End -->\n                <\/div>\n        <!-- Ipsen Content Overlay Variation two End -->\n            <\/div>\n<\/section>\n<!-- Ipsen Content Overlay End -->\n\n<!-- Ipsen Content Overlay Start -->\n<section class=\"two-col-image-section\">\n    <div class=\"container two-img-section-innner\">\n                <!-- Ipsen Content Overlay Variation Two Start -->\n                <div class=\"row section-bg-reverse\">\n                    <div class=\"col-xs-12 col-sm-12 col-md-6 column-1 order-2\">\n                        <div id=\"image-carousel\" class=\"img-video-section carousel\" data-bs-ride=\"carousel\">\n                            <div class=\"carousel-inner\">\n                                                                        <div class=\"carousel-item active\">\n                                            <img decoding=\"async\" src=\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/sites\/7\/2024\/02\/21101641\/Module-10_Oncology-pipeline_191209_1833.jpg\" title=\"Image info\" alt=\"Image info\" >\n                                        <\/div>\n                                                            <\/div>\n                                                    <\/div>\n                    <\/div>\n                    <div class=\" col-xs-12 col-sm-12 col-md-6 column-2 order-1\">\n                        <div class=\" section-content\">\n                                                                                            <h3 class=\"section-head-two\">\n                                        Notre portefeuille de produits en R&amp;D                                    <\/h3>\n                                                                                            <p class=\"section-para \">\n                                        Aux c\u00f4t\u00e9s de partenaires qui partagent notre vision, nous mettons tout en \u0153uvre pour am\u00e9liorer le quotidien des patients et de leurs aidants. Nos \u00e9quipes s&#8217;emploient jour apr\u00e8s jour \u00e0 apporter les meilleures options de traitement possibles aux patients&#8230;                                    <\/p>\n                                                                                                <a \n                                            role=\"link\" \n                                            class=\"btn-link section-btn cta-visible\" \n                                            href=\"https:\/\/www.ipsen.com\/fr\/pipeline\/\" \n                                            aria-label=\"\" \n                                            target=\"_blank\"\n                                        >\n                                            En savoir plus                                         <\/a>    \n                                    <\/button>\n                                                    <\/div>\n                    <\/div>\n                    <!-- Ipsen Content Overlay Variation Two End -->\n                <\/div>\n        <!-- Ipsen Content Overlay Variation two End -->\n            <\/div>\n<\/section>\n<!-- Ipsen Content Overlay End -->","protected":false},"excerpt":{"rendered":"","protected":false},"author":2,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"footnotes":""},"class_list":["post-94","page","type-page","status-publish","hentry","entry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v22.5 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Ipsen: Oncologie<\/title>\n<meta name=\"description\" content=\"Nos \u00e9quipes en oncologie travaillent sans rel\u00e2che pour mettre au point des m\u00e9dicaments qui prolongent la vie des patients et am\u00e9liorent leur \u00e9tat de sant\u00e9.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.ipsen.com\/be\/fr\/oncologie-cancer-prostate-tumeurs-neuroendocrines-carcinome-du-rein-lymphome-folliculaire-sarcome-epithelioide-carcinome-hepatocellulaire-thyroide\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Ipsen: Oncologie\" \/>\n<meta property=\"og:description\" content=\"Nos \u00e9quipes en oncologie travaillent sans rel\u00e2che pour mettre au point des m\u00e9dicaments qui prolongent la vie des patients et am\u00e9liorent leur \u00e9tat de sant\u00e9.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.ipsen.com\/be\/fr\/oncologie-cancer-prostate-tumeurs-neuroendocrines-carcinome-du-rein-lymphome-folliculaire-sarcome-epithelioide-carcinome-hepatocellulaire-thyroide\/\" \/>\n<meta property=\"og:site_name\" content=\"Belgium\" \/>\n<meta property=\"article:modified_time\" content=\"2025-03-27T12:05:28+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.ipsen.com\/be\/fr\/oncologie-cancer-prostate-tumeurs-neuroendocrines-carcinome-du-rein-lymphome-folliculaire-sarcome-epithelioide-carcinome-hepatocellulaire-thyroide\/\",\"url\":\"https:\/\/www.ipsen.com\/be\/fr\/oncologie-cancer-prostate-tumeurs-neuroendocrines-carcinome-du-rein-lymphome-folliculaire-sarcome-epithelioide-carcinome-hepatocellulaire-thyroide\/\",\"name\":\"Ipsen: Oncologie\",\"isPartOf\":{\"@id\":\"https:\/\/www.ipsen.com\/be\/fr\/en\/#website\"},\"datePublished\":\"2023-12-22T04:50:36+00:00\",\"dateModified\":\"2025-03-27T12:05:28+00:00\",\"description\":\"Nos \u00e9quipes en oncologie travaillent sans rel\u00e2che pour mettre au point des m\u00e9dicaments qui prolongent la vie des patients et am\u00e9liorent leur \u00e9tat de sant\u00e9.\",\"breadcrumb\":{\"@id\":\"https:\/\/www.ipsen.com\/be\/fr\/oncologie-cancer-prostate-tumeurs-neuroendocrines-carcinome-du-rein-lymphome-folliculaire-sarcome-epithelioide-carcinome-hepatocellulaire-thyroide\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.ipsen.com\/be\/fr\/oncologie-cancer-prostate-tumeurs-neuroendocrines-carcinome-du-rein-lymphome-folliculaire-sarcome-epithelioide-carcinome-hepatocellulaire-thyroide\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.ipsen.com\/be\/fr\/oncologie-cancer-prostate-tumeurs-neuroendocrines-carcinome-du-rein-lymphome-folliculaire-sarcome-epithelioide-carcinome-hepatocellulaire-thyroide\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.ipsen.com\/be\/fr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Oncologie\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.ipsen.com\/be\/fr\/en\/#website\",\"url\":\"https:\/\/www.ipsen.com\/be\/fr\/en\/\",\"name\":\"Belgium\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/www.ipsen.com\/be\/fr\/en\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.ipsen.com\/be\/fr\/en\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.ipsen.com\/be\/fr\/en\/#organization\",\"name\":\"Belgium\",\"url\":\"https:\/\/www.ipsen.com\/be\/fr\/en\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/www.ipsen.com\/be\/fr\/en\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/sites\/7\/2023\/12\/07165829\/Latest_Ipsen-logo_168x48.svg\",\"contentUrl\":\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/sites\/7\/2023\/12\/07165829\/Latest_Ipsen-logo_168x48.svg\",\"caption\":\"Belgium\"},\"image\":{\"@id\":\"https:\/\/www.ipsen.com\/be\/fr\/en\/#\/schema\/logo\/image\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Ipsen: Oncologie","description":"Nos \u00e9quipes en oncologie travaillent sans rel\u00e2che pour mettre au point des m\u00e9dicaments qui prolongent la vie des patients et am\u00e9liorent leur \u00e9tat de sant\u00e9.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.ipsen.com\/be\/fr\/oncologie-cancer-prostate-tumeurs-neuroendocrines-carcinome-du-rein-lymphome-folliculaire-sarcome-epithelioide-carcinome-hepatocellulaire-thyroide\/","og_locale":"fr_FR","og_type":"article","og_title":"Ipsen: Oncologie","og_description":"Nos \u00e9quipes en oncologie travaillent sans rel\u00e2che pour mettre au point des m\u00e9dicaments qui prolongent la vie des patients et am\u00e9liorent leur \u00e9tat de sant\u00e9.","og_url":"https:\/\/www.ipsen.com\/be\/fr\/oncologie-cancer-prostate-tumeurs-neuroendocrines-carcinome-du-rein-lymphome-folliculaire-sarcome-epithelioide-carcinome-hepatocellulaire-thyroide\/","og_site_name":"Belgium","article_modified_time":"2025-03-27T12:05:28+00:00","twitter_card":"summary_large_image","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.ipsen.com\/be\/fr\/oncologie-cancer-prostate-tumeurs-neuroendocrines-carcinome-du-rein-lymphome-folliculaire-sarcome-epithelioide-carcinome-hepatocellulaire-thyroide\/","url":"https:\/\/www.ipsen.com\/be\/fr\/oncologie-cancer-prostate-tumeurs-neuroendocrines-carcinome-du-rein-lymphome-folliculaire-sarcome-epithelioide-carcinome-hepatocellulaire-thyroide\/","name":"Ipsen: Oncologie","isPartOf":{"@id":"https:\/\/www.ipsen.com\/be\/fr\/en\/#website"},"datePublished":"2023-12-22T04:50:36+00:00","dateModified":"2025-03-27T12:05:28+00:00","description":"Nos \u00e9quipes en oncologie travaillent sans rel\u00e2che pour mettre au point des m\u00e9dicaments qui prolongent la vie des patients et am\u00e9liorent leur \u00e9tat de sant\u00e9.","breadcrumb":{"@id":"https:\/\/www.ipsen.com\/be\/fr\/oncologie-cancer-prostate-tumeurs-neuroendocrines-carcinome-du-rein-lymphome-folliculaire-sarcome-epithelioide-carcinome-hepatocellulaire-thyroide\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.ipsen.com\/be\/fr\/oncologie-cancer-prostate-tumeurs-neuroendocrines-carcinome-du-rein-lymphome-folliculaire-sarcome-epithelioide-carcinome-hepatocellulaire-thyroide\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.ipsen.com\/be\/fr\/oncologie-cancer-prostate-tumeurs-neuroendocrines-carcinome-du-rein-lymphome-folliculaire-sarcome-epithelioide-carcinome-hepatocellulaire-thyroide\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.ipsen.com\/be\/fr\/"},{"@type":"ListItem","position":2,"name":"Oncologie"}]},{"@type":"WebSite","@id":"https:\/\/www.ipsen.com\/be\/fr\/en\/#website","url":"https:\/\/www.ipsen.com\/be\/fr\/en\/","name":"Belgium","description":"","publisher":{"@id":"https:\/\/www.ipsen.com\/be\/fr\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.ipsen.com\/be\/fr\/en\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/www.ipsen.com\/be\/fr\/en\/#organization","name":"Belgium","url":"https:\/\/www.ipsen.com\/be\/fr\/en\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.ipsen.com\/be\/fr\/en\/#\/schema\/logo\/image\/","url":"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/sites\/7\/2023\/12\/07165829\/Latest_Ipsen-logo_168x48.svg","contentUrl":"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/sites\/7\/2023\/12\/07165829\/Latest_Ipsen-logo_168x48.svg","caption":"Belgium"},"image":{"@id":"https:\/\/www.ipsen.com\/be\/fr\/en\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/www.ipsen.com\/be\/fr\/wp-json\/wp\/v2\/pages\/94","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.ipsen.com\/be\/fr\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.ipsen.com\/be\/fr\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.ipsen.com\/be\/fr\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.ipsen.com\/be\/fr\/wp-json\/wp\/v2\/comments?post=94"}],"version-history":[{"count":12,"href":"https:\/\/www.ipsen.com\/be\/fr\/wp-json\/wp\/v2\/pages\/94\/revisions"}],"predecessor-version":[{"id":1296,"href":"https:\/\/www.ipsen.com\/be\/fr\/wp-json\/wp\/v2\/pages\/94\/revisions\/1296"}],"wp:attachment":[{"href":"https:\/\/www.ipsen.com\/be\/fr\/wp-json\/wp\/v2\/media?parent=94"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}